Yes, GeneDx Holdings Corp. is a publicly traded corporate entity listed on the Nasdaq stock exchange under the ticker symbol WGS. The company specializes in breakthrough genomic testing, rare disease diagnostics, and clinical exome sequencing, making its shares accessible to institutional and retail investors through standard brokerage accounts.